Business Standard

PlasmaGen Biosciences hopes for turnover of Rs 640 crore in five years

Awareness of human plasma products and their utility is still nascent

PlasmaGen BioSciences
Premium

PlasmaGen BioSciences founder Vinod Nahar with Chief Executive Ranjeet S Ajmani and Director Rahul Jain. Photo: Saggere Radhakrishna

Sohini Das
PlasmaGen BioSciences, a start-up in the niche area of plasma products, incorporated in September 2010, is working on creating a manufacturing facility near Bengaluru. It aims to touch a turnover of $100-120 million (Rs 640-800 crore) in the next five years.

Plasma products

Blood plasma is a liquid component of blood that normally holds the blood cells (red, white and platelets). Human plasma contains proteins like serum albumins, immuno-globulins, fibrinogen and clotting factors, which have  various therapeutic uses. These are used for patients with Haemophilia, fibrinogen deficiency, and burn and trauma patients, among others. It is considered safer

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in